Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AP3B2 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
mRNA | TTC27 | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-06 |
mRNA | LRRC74B | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
mRNA | CHD6 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
mRNA | GDI1 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
mRNA | SHCBP1 | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-06 |
mRNA | ZNF529 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-06 |
mRNA | RP11-574F21.3 | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-06 |
mRNA | CCDC136 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-06 |
mRNA | CYTH2 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |